home / stock / argnf / argnf news


ARGNF News and Press, Argen X NV From 07/30/22

Stock Information

Company Name: Argen X NV
Stock Symbol: ARGNF
Market: OTC
Website: argenx.com

Menu

ARGNF ARGNF Quote ARGNF Short ARGNF News ARGNF Articles ARGNF Message Board
Get ARGNF Alerts

News, Short Squeeze, Breakout and More Instantly...

ARGNF - ClearBridge Investments Global Growth Strategy Q2 2022 Commentary

ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Growth stocks continued to trail value through challengin...

ARGNF - argenx SE (ARGX) CEO Tim Van Hauwermeiren on Q2 2022 Results - Earnings Call Transcript

argenx SE (ARGX) Q2 2022 Earnings Conference Call July 28, 2022, 08:30 AM ET Company Participants Beth DelGiacco - VP Corporate Communications and IR Tim Van Hauwermeiren - CEO Karl Gubitz - CFO Keith Woods - COO Conference Call Participants Danie...

ARGNF - argenx SE 2022 Q2 - Results - Earnings Call Presentation

The following slide deck was published by argenx SE in conjunction with their 2022 Q2 earnings call. For further details see: argenx SE 2022 Q2 - Results - Earnings Call Presentation

ARGNF - Baron Health Care Fund Q2 2022 Shareholder Letter

Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. In the quarter ended June 30, 2022, Baron Health Care Fund declined 10.00% compared with the Benchmark. We are partic...

ARGNF - ClearBridge International Growth ACWI Ex-US Strategy Commentary Q2 2022

Growth stocks continued to trail value through challenging macro and market conditions but the magnitude of underperformance has been narrowing, supporting Strategy results. We are closely watching corporate results to determine the near-term outlook for international equities. How co...

ARGNF - ClearBridge International Growth EAFE Portfolio Manager Commentary Q2 2022

Growth stocks continued to trail value through challenging macro and market conditions but the magnitude of underperformance has been narrowing, supporting Strategy results. To manage through the myriad uncertainties in the current environment, we continue to rely on secular and struc...

ARGNF - Tracking Baker Brothers Portfolio - Q1 2022 Update

Baker Brothers’ 13F portfolio value decreased from $20.55B to $17.40B this quarter. Horizon Therapeutics was increased while decreasing Legend Biotech. The top three positions are Seagen, Incyte Corporation, and BeiGene, and they add up to almost 68% of the portfolio. ...

ARGNF - Baron Health Care Fund Q1 2022 Shareholder Letter

Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. In the quarter ended March 31, 2022, Baron Health Care Fund (the “Fund”) declined 9.93% (Institutional Shar...

ARGNF - argenx SE - ADR (ARGX) Investor Presentation - Slideshow

The following slide deck was published by argenx SE in conjunction with this event. For further details see: argenx SE - ADR (ARGX) Investor Presentation - Slideshow

ARGNF - argenx SE 2022 Q1 - Results - Earnings Call Presentation

The following slide deck was published by argenx SE in conjunction with their 2022 Q1 earnings call. For further details see: argenx SE 2022 Q1 - Results - Earnings Call Presentation

Previous 10 Next 10